98 related articles for article (PubMed ID: 5012915)
21. [Hormone determinations during 17-hydroxyprogesterone-capronate therapy].
Sas M; Morvay J
Zentralbl Gynakol; 1967 Oct; 89(43):1585-91. PubMed ID: 5590663
[No Abstract] [Full Text] [Related]
22. [Serum tumor marker TPS (tissue polypeptide-specific antigen)].
Sergeeva NS; Dubovetskaia OB; Marshutina NV; Rodina IA; Mishunina MP; Beliaeva IG; Nesterova OA; Sergeeva VS
Vopr Onkol; 2004; 50(6):637-43. PubMed ID: 15755055
[No Abstract] [Full Text] [Related]
23. [The pentosephosphate pathway or Dickens-Horecker cycle in tumors of the female genital system. I. Glucose-6-phosphate dehydrogenase (G6PDH) activity in vaginal secretion in the course of malignanty neoplasms of the cervix and uterus].
Azzarini V; Salvatores D; Torre GC
Cancro; 1969; 22(6):599-605. PubMed ID: 5403781
[No Abstract] [Full Text] [Related]
24. Coexpression of cholesterol sulfate and cytokeratin as tumor markers in well-differentiated squamous cell carcinoma of the human uterine cervix.
Kiguchi K; Iwamori M; Yamanouchi S; Ishiwata I; Saga M; Amemiya A
Clin Cancer Res; 1998 Dec; 4(12):2985-90. PubMed ID: 9865910
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs].
Yamada E
Igaku Kenkyu; 1982 Nov; 52(5):269-87. PubMed ID: 6821182
[No Abstract] [Full Text] [Related]
26. Urine excretion of tumor-associated antigens by patients with gynecologic neoplasms.
Rote NS; Smith WG; Johnson GH
Gynecol Oncol; 1980 Jun; 9(3):370-5. PubMed ID: 6991377
[No Abstract] [Full Text] [Related]
27. [Progress in the study on correlation of expression of survivin gene and gynecologic tumors].
Deng KX; Zhong L
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):566-8. PubMed ID: 15363365
[No Abstract] [Full Text] [Related]
28. [Deoxicytidylate aminohydrolase activity in neoplastic and non-neoplastic tissues of the human female genital zone].
Mangoni C; Magri E; Castaldo A; Manzi A
Boll Soc Ital Biol Sper; 1964 Sep; 40(18):1093-4. PubMed ID: 5876949
[No Abstract] [Full Text] [Related]
29. [Specifics of metabolic disorders in patients with "hormone-associated neoplastic" syndromes].
Rybin EP; Bershtein LM; Tsyrlina EV; Kovalenko IG; Gamaiunova VB; Evtushenko TP; Bokhman IV
Vopr Onkol; 1996; 42(3):41-4. PubMed ID: 8801740
[TBL] [Abstract][Full Text] [Related]
30. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
31. Copper and zinc concentrations in normal and malignant tissues of ovary, uterus and cervix.
Jendryczko A; Drózdz M; Tomala J; Magner K; Dzieciuchowicz L
Ginekol Pol; 1985 Nov; 56(11):677-81. PubMed ID: 4092997
[No Abstract] [Full Text] [Related]
32. [Studies of cases with various malignant tumors].
Protzen H
Zentralbl Gynakol; 1967 Jul; 89(28):1016-23. PubMed ID: 5586400
[No Abstract] [Full Text] [Related]
33. [Sulfur containing compounds of proteins and protein-less filtrates of human uterine tumors].
Misheneva VS; Goriukhina TA
Vopr Onkol; 1970; 16(12):17-23. PubMed ID: 5516754
[No Abstract] [Full Text] [Related]
34. Hormone sensitivity of gynecological tumor cells in tissue culture.
Simon WE; Hölzel F
J Cancer Res Clin Oncol; 1979 Jul; 94(3):307-23. PubMed ID: 479269
[TBL] [Abstract][Full Text] [Related]
35. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
Han SW; He B; Tang QP
Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
[TBL] [Abstract][Full Text] [Related]
36. Binding of estradiol-17-beta to human cancer tissue of the female genital tract.
Terenius L; Lindell A; Persson BH
Cancer Res; 1971 Dec; 31(12):1895-8. PubMed ID: 5120287
[No Abstract] [Full Text] [Related]
37. Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152.
Emons G; Sindermann H; Engel J; Schally AV; Gründker C
Neuroendocrinology; 2009; 90(1):15-8. PubMed ID: 19521066
[TBL] [Abstract][Full Text] [Related]
38. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
[TBL] [Abstract][Full Text] [Related]
39. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
[TBL] [Abstract][Full Text] [Related]
40. [T and B lymphocytes, IgG, IgA and IgM in women with genital neoplasms].
Paruch J; Lisiewicz J; Liber Z
Wiad Lek; 1982 Oct; 35(18):1143-8. PubMed ID: 7179988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
